{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:21Z","timestamp":1792783401558,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82170122"],"award-info":[{"award-number":["82170122"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Beijing Natural Science Foundation","award":["7252035"],"award-info":[{"award-number":["7252035"]}]},{"name":"the high level discipline construction project of Beijing Anzhen Hospital Affiliated to Capital Medical University","award":["2024AZC4001"],"award-info":[{"award-number":["2024AZC4001"]}],"id":[{"id":"https:\/\/ror.org\/02h2j1586","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the high level discipline construction project of Beijing Anzhen Hospital Affiliated to Capital Medical University","award":["2025AZB6016"],"award-info":[{"award-number":["2025AZB6016"]}],"id":[{"id":"https:\/\/ror.org\/02h2j1586","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"DOI":"10.1007\/s40121-026-01449-7","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:14:20Z","timestamp":1791695660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time-Dependent Prognostic Value of the sCD25-to-Ferritin Ratio in Chronic Active Epstein\u2013Barr Virus-Associated Hemophagocytic Lymphohistiocytosis"],"prefix":"10.1007","author":[{"given":"Yingxin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiankuo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-5281","authenticated-orcid":false,"given":"Yue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"issue":"2","key":"1449_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/pathogens1020156","volume":"1","author":"S Tzellos","year":"2012","unstructured":"Tzellos S, Farrell PJ. Epstein\u2013Barr virus sequence variation-biology and disease. Pathog (Basel). 2012;1(2):156\u201374.","journal-title":"Pathog (Basel)"},{"issue":"3","key":"1449_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386.","journal-title":"Blood"},{"issue":"2","key":"1449_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.V98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, et al. Clinical and virologic characteristics of chronic active Epstein\u2013Barr virus infection. Blood. 2001;98(2):280\u20136.","journal-title":"Blood"},{"issue":"1","key":"1449_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00277-011-1239-7","volume":"91","author":"C Tabata","year":"2012","unstructured":"Tabata C, Tabata R. Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndrome. Ann Hematol. 2012;91(1):63\u201371.","journal-title":"Ann Hematol"},{"issue":"11","key":"1449_CR5","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.1007\/s00432-023-04781-4","volume":"149","author":"H Zou","year":"2023","unstructured":"Zou H, He L, Hue Z, Liu M, Yao S, Zhu Y, et al. Serum sCD25\/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation. J Cancer Res Clin Oncol. 2023;149(11):8521\u201333.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"1449_CR6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1182\/blood.2021012764","volume":"139","author":"A Zoref-Lorenz","year":"2022","unstructured":"Zoref-Lorenz A, Murakami J, Hofstetter L, Iyer S, Alotaibi AS, Mohamed SF, et al. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022;139(7):1098\u2013110.","journal-title":"Blood"},{"issue":"5","key":"1449_CR7","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1182\/bloodadvances.2022007953","volume":"7","author":"T Wimmer","year":"2023","unstructured":"Wimmer T, Mattes R, Stemmler HJ, Hauck F, Schulze-Koops H, Stecher SS, et al. sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study. Blood Adv. 2023;7(5):832\u201344.","journal-title":"Blood Adv"},{"issue":"2","key":"1449_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41375-024-02135-8","volume":"38","author":"J Knauft","year":"2024","unstructured":"Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Ros\u00e9e P, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia. 2024;38(2):235\u201349.","journal-title":"Leukemia"},{"issue":"7","key":"1449_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/pbc.24980","volume":"61","author":"K Kogawa","year":"2014","unstructured":"Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, et al. Prognostic factors of Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014;61(7):1257\u201362.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1449_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.103061","volume":"19","author":"F Hu","year":"2026","unstructured":"Hu F, Zhan J, Peng M, Hu H, Zheng X, Ren D, et al. Development and validation of a risk stratification score for hemophagocytic syndrome in chronic active Epstein\u2013Barr virus infection: a 10-year retrospective cohort study. J Infect Public Health. 2026;19(3):103061.","journal-title":"J Infect Public Health"},{"key":"1449_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.826080","volume":"9","author":"X He","year":"2022","unstructured":"He X, Wang J, Song D, Wang Z. Development of a nomogram to predict the risk of chronic active Epstein\u2013Barr virus infection progressing to hemophagocytic lymphohistiocytosis. Front Med (Lausanne). 2022;9:826080.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"1449_CR12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00277-017-3072-0","volume":"96","author":"ZK Otrock","year":"2017","unstructured":"Otrock ZK, Hock KG, Riley SB, de Witte T, Eby CS, Scott MG. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol. 2017;96(10):1667\u201372.","journal-title":"Ann Hematol"},{"issue":"9","key":"1449_CR13","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","volume":"116","author":"LA Cohen","year":"2010","unstructured":"Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, Crooks DR, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010;116(9):1574\u201384.","journal-title":"Blood"},{"issue":"1","key":"1449_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/07853890.2022.2027513","volume":"54","author":"Z Hua","year":"2022","unstructured":"Hua Z, He L, Zhang R, Liu M, Wang Z, Wang Y. Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy. Ann Med. 2022;54(1):283\u201392.","journal-title":"Ann Med"},{"issue":"5","key":"1449_CR15","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","volume":"135","author":"LA Rubin","year":"1985","unstructured":"Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985;135(5):3172\u20137.","journal-title":"J Immunol"},{"issue":"5","key":"1449_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","volume":"93","author":"T Tsuji","year":"2014","unstructured":"Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H. A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol. 2014;93(5):821\u20136.","journal-title":"Ann Hematol"},{"issue":"11","key":"1449_CR17","first-page":"1426","volume":"123","author":"YK Jin","year":"2010","unstructured":"Jin YK, Xie ZD, Yang S, Lu G, Shen KL. Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China. Chin Med J (Engl). 2010;123(11):1426\u201330.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"1449_CR18","first-page":"183","volume":"89","author":"S Imashuku","year":"2004","unstructured":"Imashuku S, Teramura T, Tauchi H, Ishida Y, Otoh Y, Sawada M, et al. Longitudinal follow-up of patients with Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica. 2004;89(2):183\u20138.","journal-title":"Haematologica"},{"issue":"2","key":"1449_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014032","volume":"98","author":"YD Wang","year":"2019","unstructured":"Wang YD, Wu LL, Ma LY, Shang XB, Li ZY, Wang W, et al. Chronic active EBV infection associated with NK cell lymphoma and hemophagocytic lymphohistiocytosis in a 27-year-old woman: a case report. Med (Baltim). 2019;98(2):e14032.","journal-title":"Med (Baltim)"},{"issue":"26","key":"1449_CR20","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","volume":"131","author":"CM Bollard","year":"2018","unstructured":"Bollard CM, Cohen JI. How I treat T-cell chronic active Epstein\u2013Barr virus disease. Blood. 2018;131(26):2899\u2013905.","journal-title":"Blood"},{"issue":"2","key":"1449_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1182\/bloodadvances.2021005291","volume":"6","author":"BJ D\u00e1vila Salda\u00f1a","year":"2022","unstructured":"D\u00e1vila Salda\u00f1a BJ, John T, Bonifant C, Buchbinder D, Chandra S, Chandrakasan S, et al. High risk of relapsed disease in patients with NK\/T-cell chronic active Epstein\u2013Barr virus disease outside of Asia. Blood Adv. 2022;6(2):452\u20139.","journal-title":"Blood Adv"},{"issue":"4","key":"1449_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12288-020-01258-z","volume":"36","author":"A Garg","year":"2020","unstructured":"Garg A, Shah S, Patel K, Shah K, Anand A, Panchal H, et al. Post-transplant hemophagocytic lymphohistiocytosis in benign hematological disorders: experience of 4 cases with review of literature. Indian J Hematol Blood Transfus. 2020;36(4):674\u20139.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"4","key":"1449_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","volume":"105","author":"A Sawada","year":"2017","unstructured":"Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein\u2013Barr virus infection. Int J Hematol. 2017;105(4):406\u201318.","journal-title":"Int J Hematol"},{"key":"1449_CR24","doi-asserted-by":"publisher","first-page":"1678519","DOI":"10.3389\/fimmu.2025.1678519","volume":"16","author":"P Wang","year":"2025","unstructured":"Wang P, Dong D, Huang S, Wang L, Zhang H, Li Y, et al. Case report: two cases of chronic active Epstein\u2013Barr virus disease presenting as refractory sinusitis. Front Immunol. 2025;16:1678519.","journal-title":"Front Immunol"},{"issue":"10","key":"1449_CR25","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/1097-0142(19891115)64:10<2019::AID-CNCR2820641009>3.0.CO;2-S","volume":"64","author":"R Zambello","year":"1989","unstructured":"Zambello R, Pizzolo G, Trentin L, Agostini C, Chisesi T, Vinante F, et al. Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes. Cancer. 1989;64(10):2019\u201323.","journal-title":"Cancer"},{"key":"1449_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01867","volume":"8","author":"H Kimura","year":"2017","unstructured":"Kimura H, Cohen JI. Chronic active Epstein\u2013Barr virus disease. Front Immunol. 2017;8:1867.","journal-title":"Front Immunol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01449-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01449-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01449-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:01:57Z","timestamp":1791741717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01449-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":26,"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01449-7","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"assertion":[{"value":"1 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors (Yingxin Zhua, Tiankuo Gaoa, Xinyang Zhanga, Chen Gonga, Chun Yanga, Xuefeng He and Yue Song) declare that they have no competing interests or conflicts of interest with respect to the research, authorship, and\/or publication of this article. No financial or personal relationships exist that could inappropriately influence or bias this work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Capital Medical University affiliated Beijing Anzhen Hospital and The First Affiliated Hospital of Soochow University. It was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients or their legal guardians.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}